Posts

Posted on

McEwen Q4 and Year-End 2025 Results Conference Call

TORONTO, March 09, 2026 (GLOBE NEWSWIRE) — McEwen Inc. (NYSE/TSX: MUX) (“McEwen”, “MUX” or the “Company”) invites you to join our Q4 and year-end 2025 conference call that will take place on Thursday, March 12, 2026,at 3:00 PM EDT. Management will discuss our financial results and project developments and follow with a question-and-answer session. Participants can ask questions directly over the phone during the webcast.

Thursday,

March 12, 2026

at 3:00 PM EDT
 Toll Free North America: (888) 210-3454
Toll Dial-In: (646) 960-0130
International Dial-In: https://events.q4irportal.com/custom/access/2324/
Conference ID Number: 3232920
Webcast Link: https://events.q4inc.com/attendee/594254930/guest


An archived replay of the webcast will be available approximately two hours after the conclusion of the live event. Access the replay on the Company’s media page at https://www.mcewenmining.com/media.

ABOUT MCEWEN

McEwen shares trade on both the NYSE and TSX under the ticker MUX.

McEwen provides its shareholders with exposure to a growing base of gold and silver production in addition to a very large copper development project, all in the Americas. The gold and silver mines are in prolific mineral-rich regions of the world, the Cortez Trend in Nevada, USA, the Timmins district of Ontario and Flin Flon in Manitoba, Canada, and the Deseado Massif in Santa Cruz province, Argentina. McEwen is also reactivating its gold and silver El Gallo Mine in Mexico.

The Company has a 46.3% interest in McEwen Copper, which owns the large, long-life, advanced-stage Los Azules copper development project in San Juan province, Argentina – a region that hosts some of the country’s largest copper deposits. According to the last financing for McEwen Copper, the implied value of McEwen’s ownership interest is US$456 million. The Los Azules copper project is designed to be one of the world’s first regenerative copper mines and carbon neutral by 2038. Its Feasibility Study results were announced in the press release dated October 7, 2025.

McEwen also recently purchased 27.3% of Paragon Advanced Labs Inc., a newly listed public company that is deploying PhotonAssay™ units around the world, a technology that the Company believes is poised to become the new industry standard for assaying precious and base metals, with Paragon aiming to be one of the leading service providers.

Chairman and Chief Owner Rob McEwen has invested over US$250 million personally and takes a salary of $1 per year, aligning his interests with shareholders. He is a recipient of the Order of Canada, a member of the Canadian Mining Hall of Fame and a winner of the EY Entrepreneur of the Year (Energy) award. His objective is to build MUX’s profitability and share value and ultimately implement a dividend policy, as he did while building Goldcorp Inc.

CAUTION CONCERNING FORWARD-LOOKING STATEMENTS

This news release contains certain forward-looking statements and information, including “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. The forward-looking statements and information expressed, are as at the date of this news release and are McEwen Inc.’s (the “Company”) estimates, forecasts, projections, expectations or beliefs as to future events and results. Forward-looking statements and information are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive uncertainties, risks and contingencies, and there can be no assurance that such statements and information will prove to be accurate. Therefore, actual results and future events could differ materially from those anticipated in such statements and information. Risks and uncertainties that could cause results or future events to differ materially from current expectations expressed or implied by the forward-looking statements and information include, but are not limited to, fluctuations in the market price of precious metals, mining industry risks, political, economic, social and security risks associated with foreign operations, the ability of the Company to receive or receive in a timely manner permits or other approvals required in connection with operations, risks associated with the construction of mining operations and commencement of production and the projected costs thereof, risks related to litigation, the state of the capital markets, environmental risks and hazards, uncertainty as to calculation of mineral resources and reserves, foreign exchange volatility, foreign exchange controls, foreign currency risk, and other risks. Readers should not place undue reliance on forward-looking statements or information included herein, which speak only as of the date hereof. The Company undertakes no obligation to reissue or update forward-looking statements or information as a result of new information or events after the date hereof except as may be required by law. See McEwen Inc.’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and other filings with the Securities and Exchange Commission, under the caption “Risk Factors”, for additional information on risks, uncertainties and other factors relating to the forward-looking statements and information regarding the Company. All forward-looking statements and information made in this news release are qualified by this cautionary statement.

The NYSE and TSX have not reviewed and do not accept responsibility for the adequacy or accuracy of the contents of this news release, which has been prepared by the management of McEwen.

Want News Fast?

Subscribe to our email list:
https://www.mcewenmining.com/contact-us/#section=followUs

and receive news as it happens!!

             
 
WEB SITE
 
SOCIAL MEDIA
 		     
 
www.mcewenmining.com
  McEwen
 Facebook:
facebook.com/mceweninc
 		 
      LinkedIn:
linkedin.com/company/mceweninc
 
 
CONTACT INFORMATION
 		  X:
X.com/mceweninc
 		 
  150 King Street West   Instagram:
instagram.com/mceweninc
 		 
  Suite 2800, PO Box 24          
  Toronto, ON, Canada   McEwen
Copper
 Facebook:
facebook.com/ mcewencopper
 		 
  M5H 1J9   LinkedIn:
linkedin.com/company/mcewencopper
 		 
      X:
X.com/mcewencopper
 		 
 
Relationship with Investors:
  Instagram:
instagram.com/mcewencopper
 
  (866)-441-0690 – Toll free line          
  (647)-258-0395   Rob McEwen
 Facebook:
facebook.com/mcewenrob
 
  Mihaela Iancu ext. 320   LinkedIn:
linkedin.com/in/robert-mcewen-646ab24
 		 
 
[email protected]
  X:
X.com/robmcewenmux
 
             



Posted on

Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc. – HIMS

Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc. – HIMS

NEW YORK CITY & NEW ORLEANS–(BUSINESS WIRE)–
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS).

On June 23, 2025, Novo Nordisk announced that it was terminating its partnership with Hims & Hers, disclosing that the Company had “failed to adhere to the law which prohibits mass sales of compounded drugs under the false guise of ‘personalization’ and are disseminating deceptive marketing that put patient safety at risk,” and that “the ‘semaglutide’ active pharmaceutical ingredients that are in the knock-off drugs sold by telehealth entities and compounding pharmacies” may contain “unsafe and illicit foreign ingredients.”

Thereafter, the Company and certain of its executives were sued in a securities class action lawsuit, charging them with failing to disclose material information during the Class Period including alleged misrepresentations regarding the Company’s business, operations, and prospects, and in particular, regarding the business relationship between the Company and Novo Nordisk, violating federal securities laws. Recently, the Court presiding over the case denied the Company’s motion to dismiss, allowing the case to move forward.

KSF’s investigation is focusing on whether Hims & Hers’ officers and/or directors breached their fiduciary duties to its shareholders or otherwise violated state or federal laws.

If you have information that would assist KSF in its investigation, or have been a long-term holder of Hims & Hers shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-833-938-0905 or email KSF Managing Partner Lewis Kahn ([email protected]), or visit https://www.ksfcounsel.com/cases/nyse-hims/ to learn more.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors – in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.

TOP 10 Plaintiff Law Firms – According to ISS Securities Class Action Services

To learn more about KSF, you may visit www.ksfcounsel.com.

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn

Kahn Swick & Foti, LLC

Lewis Kahn, Managing Partner

[email protected]

1-877-515-1850

1100 Poydras St., Suite 960

New Orleans, LA 70163

KEYWORDS: Louisiana New York United States North America

INDUSTRY KEYWORDS: Professional Services Class Action Lawsuit

MEDIA:

Logo
Logo
Posted on

INVESTOR ALERT: Navan, Inc. Investors with Substantial Losses Have Opportunity to Lead the Navan Class Action – RGRD Law

SAN DIEGO, March 09, 2026 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Navan, Inc. (NASDAQ: NAVN) common stock pursuant and/or traceable to Navan’s offering documents issued in connection with Navan’s October 31, 2025 initial public offering (the “IPO”), have until April 24, 2026 to seek appointment as lead plaintiff of the Navan class action lawsuit. Captioned McCown v. Navan, Inc., No. 26-cv-01550 (N.D. Cal.), the Navan class action lawsuit charges Navan as well as certain of Navan’s top executives and directors and underwriters of the IPO with violations of the Securities Act of 1933.

If you suffered substantial losses and wish to serve as lead plaintiff of the

Navan

class action lawsuit, please provide your information here:


https://www.rgrdlaw.com/cases-navan-inc-class-action-lawsuit-navn.html

You can also contact attorney

J.C. Sanchez

of Robbins Geller by calling 800/449-4900 or via e-mail at

[email protected]

.

CASE ALLEGATIONS: Navan operates an AI-powered software platform to simplify the travel and expense experience, benefiting users, customers, and suppliers. According to the Navan class action lawsuit, on or about October 31, 2025, Navan conducted its IPO, issuing nearly 37 million shares to the public at the offering price of $25.00 per share.

The Navan class action lawsuit alleges that the IPO’s offering documents were materially false and/or misleading and/or omitted to state that Navan would increase its sales and marketing expenses by 39% just months after the IPO to sustain its revenue, Gross Booking Volume, and usage yield growth.

The Navan class action lawsuit further alleges that on December 15, 2025, Navan reported its earnings for the quarter ended October 31, 2025, and disclosed that it increased its sales and marketing expenses to nearly $95 million, a 39% increase from its $68.5 million sales and marketing expenses in the quarter ending July 31, 2025. On this news, the price of Navan stock fell nearly 12%, according to the Navan class action lawsuit.

The complaint alleges that by the commencement of the Navan class action lawsuit, the price of Navan stock has traded as low as $9.20 per share, a nearly 63% decline from the $25.00 per share IPO price.

THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired Navan common stock pursuant and/or traceable to the IPO to seek appointment as lead plaintiff in the Navan class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the Navan investor class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the Navan shareholder class action lawsuit. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Navan class action lawsuit.

ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world’s leading law firms representing investors in securities fraud and shareholder rights litigation. Our Firm ranked #1 on the most recent ISS Securities Class Action Services Top 50 Report, recovering more than $916 million for investors in 2025. This marks our fourth #1 ranking in the past five years. And in those five years alone, Robbins Geller recovered $8.4 billion for investors – $3.4 billion more than any other law firm. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs’ firms in the world, and the Firm’s attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information:


https://www.rgrdlaw.com/services-litigation-securities-fraud.html

Past results do not guarantee future outcomes. 
Services may be performed by attorneys in any of our offices. 

Contact:
        Robbins Geller Rudman & Dowd LLP
        J.C. Sanchez
        655 W. Broadway, Suite 1900, San Diego, CA 92101
        800-449-4900
        [email protected]



Posted on

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Soleno Therapeutics, Inc. (SLNO)

NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) — Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of all persons or entities who purchased or otherwise acquired Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ: SLNO) securities between March 26, 2025 and November 4, 2025, inclusive (the “Class Period”).

The Complaint alleges that Defendants failed to disclose to investors that: (a) that the Soleno Phase 3 clinical trial program for DCCR had systematically downplayed, misrepresented, and/or concealed significant evidence of safety concerns potentially related to the administration of DCCR, including issues related to excess fluid retention in clinical trial participants; (b) that, as a result of (a) above, the administration of DCCR to treat hyperphagia in individuals with PWS posed materially greater safety risks than disclosed by the Company or its executives; and (c) that, as a result of (a)-(b) above, DCCR had materially lower commercial viability and undisclosed risks related to the likelihood of significant and widespread adverse events after its commercial launch, including risks related to patient discontinuation rates, lower patient adoption, prescriber reluctance, adverse regulatory action, and potential reputational and legal fallout.

Investors who purchased or otherwise acquired shares of Soleno should contact the Firm prior to the May 5, 2026 lead plaintiff motion deadline. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected].

Please visit our website at http://www.gme-law.com for more information about the firm.



Posted on

Molina Healthcare Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Molina Healthcare, Inc. – MOH

Molina Healthcare Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Molina Healthcare, Inc. – MOH

NEW YORK CITY & NEW ORLEANS–(BUSINESS WIRE)–
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH).

On July 23, 2025, the Company reported its financial results for the second quarter ended June 30, 2025 and cut its full-year 2025 earnings guidance, disclosing that “GAAP net income was $4.75 per diluted share for the second quarter of 2025, a decrease of 8% year over year” and that it “now expects its full year 2025 adjusted earnings to be no less than $19.00 per diluted share,” a 13.6% cut to guidance of earnings per share at the midpoint, from the cut to guidance announced less than two weeks earlier. The Company also cut its guidance for its full year 2025 GAAP net income 27% to $912 million. The Company attributed its results to a “challenging medical cost trend environment,” including “utilization of behavioral health, pharmacy, and inpatient and outpatient services.”

Thereafter, the Company and certain of its executives were sued in a securities class action lawsuit, charging them with failing to disclose material information during the Class Period, violating federal securities laws.

KSF’s investigation is focusing on whether Molina’s officers and/or directors breached their fiduciary duties to its shareholders or otherwise violated state or federal laws.

If you have information that would assist KSF in its investigation, or have been a long-term holder of Molina shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-833-938-0905 or email KSF Managing Partner Lewis Kahn ([email protected]), or visit https://www.ksfcounsel.com/cases/nyse-moh/ to learn more.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors – in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.

TOP 10 Plaintiff Law Firms – According to ISS Securities Class Action Services

To learn more about KSF, you may visit www.ksfcounsel.com.

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn

Kahn Swick & Foti, LLC

Lewis Kahn, Managing Partner

[email protected]

1-877-515-1850

1100 Poydras St., Suite 960

New Orleans, LA 70163

KEYWORDS: Louisiana New York United States North America

INDUSTRY KEYWORDS: Professional Services Class Action Lawsuit

MEDIA:

Logo
Logo
Posted on

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Nektar Therapeutics (NKTR)

NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) — Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of all persons or entities who purchased or otherwise acquired Nektar Therapeutics (“Nektar” or the “Company”) (NASDAQ: NKTR) securities between February 26, 2025, and December 15, 2025, inclusive (the “Class Period”).

The Complaint alleges that Defendants failed to disclose to investors that: (i) enrollment in the REZOLVE-AA trial had not followed applicable instructions and protocol standards; (ii) the foregoing was likely to have a significant negative impact on the REZOLVE-AA trial’s results; (iii) accordingly, the REZOLVE-AA trial’s overall integrity and prospects were overstated; and (iv) as a result, Defendants’ public statements were materially false and misleading at all relevant times.

Investors who purchased or otherwise acquired shares of Nektar should contact the Firm prior to the May 5, 2026 lead plaintiff motion deadline. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected].

Please visit our website at http://www.gme-law.com for more information about the firm.



Posted on

Schwab Trading Activity Index™: STAX Score Soared in February, Defying AI Panic

Schwab Trading Activity Index™: STAX Score Soared in February, Defying AI Panic

Schwab clients were enthusiastic buyers in February; STAX has now outgained the S&P 500® index (SPX) in six of the last seven months.

WESTLAKE, Texas–(BUSINESS WIRE)–
The Schwab Trading Activity Index™ (STAX) increased to 57.32 in February, up from its score of 49.96 in January. The only index of its kind, the STAX is a proprietary, behavior-based index that analyzes retail investor stock positions and trading activity from Schwab’s millions of client accounts to illuminate what investors were actually doing and how they were positioned in the markets each month.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260309776813/en/

“February’s score represented the biggest month-over-month percentage gain since late 2020, and the highest score we’ve seen since February 2022,” said Joe Mazzola, Head Trading and Derivatives Strategist at Charles Schwab. “The trading behavior we saw among our retail clients tells a clear story: the AI-driven panic that rattled the markets in February was likely overblown and, more than anything, may have represented an opportune time to pick up some names that had taken a perhaps unfair beating.”

In February, the S&P 500 Index struggled and failed to regain its January highs, generally trading in a tight range between 6,800 and 7,000 most of the month before conflict with Iran began in early March. Volatility rose in February, partly due to geopolitical concerns.

In addition, markets suffered slings and arrows throughout February stemming from worries about AI competition for functions currently performed by software firms, sending shares of that technology sub-sector to 25% losses year-to-date by the end of the month. Financial names were hurt by AI substitution worries, too, along with concerns about private credit liquidity due to private asset management firms’ large positions in software.

The fourth quarter earnings season rolled along with mostly positive numbers, and by the end of February, 97% of S&P 500 companies had reported. Earnings growth was 14.2% year over year, according to FactSet, well above expectations of about 8%.

Economic data in February was mixed. Fourth quarter gross domestic product (GDP) growth came in well below estimates, but January jobs growth of 130,000 easily topped consensus.

More affluent and older investors led the buying among Schwab clients last month, with Generation X, born between 1965 and 1980, topping the list of age groups. Popular names bought by all Schwab clients during the period included:

  • Amazon.com Inc. (AMZN)

  • Microsoft Corp. (MSFT)

  • NVIDIA Corp. (NVDA)

  • Palantir Technologies Inc. (PLTR)

  • Netflix Inc. (NFLX)

Names net sold by Schwab clients during the period included:

  • Meta Platforms Inc. (META)

  • Apple Inc. (AAPL)

  • Verizon Communications Inc. (VZ)

  • Costco Wholesale Corp. (COST)

  • AT&T Inc. (T)

About the STAX

The STAX value is calculated based on a complex proprietary formula. Each month, Schwab pulls a sample from its client base of millions of funded accounts, which includes accounts that completed a trade in the past month. The holdings and positions of this statistically significant sample are evaluated to calculate individual scores, and the median of those scores represents the monthly STAX.

For more information on the Schwab Trading Activity Index, please visit www.schwab.com/investment-research/stax. Additionally, Schwab clients can chart the STAX using the symbol $STAX in either the thinkorswim® or thinkorswim Mobile platforms.

Investing involves risk, including loss of principal. Past performance is no guarantee of future results.

Content intended for educational/informational purposes only. Not investment advice, or a recommendation of any security, strategy, or account type.

Historical data should not be used alone when making investment decisions. Please consult other sources of information and consider your individual financial position and goals before making an independent investment decision.

The STAX is not a tradable index. The STAX should not be used as an indicator or predictor of future client trading volume or financial performance for Schwab.

About Charles Schwab

At Charles Schwab, we believe in the power of investing to help individuals create a better tomorrow. We have a history of challenging the status quo in our industry, innovating in ways that benefit investors and the advisors and employers who serve them, and championing our clients’ goals with passion and integrity.

More information is available at aboutschwab.com. Follow us on X, Facebook, YouTube, and LinkedIn.

0326-LCR6

At the Company

Margaret Farrell

Director, Corporate Communications

(203) 434-2240

[email protected]

KEYWORDS: Texas United States North America

INDUSTRY KEYWORDS: Personal Finance Finance Consulting Professional Services Asset Management

MEDIA:

Logo
Logo
Posted on

Surgery Partners, Inc. to Present at Upcoming Investor Conference

BRENTWOOD, Tenn., March 09, 2026 (GLOBE NEWSWIRE) — Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), is scheduled to meet with investors at the Barclays 28th Annual Global Healthcare Conference, including a presentation on Tuesday, March 10, 2026, at 2:30 p.m. (Eastern Time).

Interested investors and other parties may listen to a simultaneous webcast of the event through the investor relations section of the company’s website at www.surgerypartners.com. The replay will also be available on this same website for a limited time following the call.

To learn more about Surgery Partners, please visit the Company’s website at www.surgerypartners.com. Surgery Partners uses its website as a channel of distribution for material Company information. Financial and other material information regarding Surgery Partners is routinely posted on the Company’s website and is readily accessible.

About Surgery Partners

Headquartered in Brentwood, Tennessee, Surgery Partners is a leading healthcare services company with a differentiated outpatient delivery model focused on providing high quality, cost effective solutions for surgical and related ancillary care in support of both patients and physicians. Founded in 2004, Surgery Partners is one of the largest and fastest growing surgical services businesses in the country, with more than 200 locations in 30 states, including ambulatory surgery centers, surgical hospitals, multi-specialty physician practices and urgent care facilities. For additional information, visit www.surgerypartners.com.

Contact:

Surgery Partners Investor Relations
(615) 234-8940
[email protected]



Posted on

Park Aerospace Corp. Declares Cash Dividend

NEWTON, Kan., March 09, 2026 (GLOBE NEWSWIRE) — The Board of Directors of Park Aerospace Corp. (NYSE-PKE) has declared a regular quarterly cash dividend of $0.125 per share payable May 4, 2026 to shareholders of record at the close of business on April 2, 2026.

Park has paid 41 consecutive years of uninterrupted regular, quarterly cash dividends, without ever skipping a dividend payment or reducing the amount of the dividend.

The Company has paid $611.0 million in cash dividends, or $29.85 per share, since the beginning of the Company’s 2005 fiscal year.

Park Aerospace Corp. develops and manufactures solution and hot-melt advanced composite materials used to produce composite structures for the global aerospace markets. Park’s advanced composite materials include film adhesives (Aeroadhere®) and lightning strike protection materials (Electroglide®). Park offers an array of composite materials specifically designed for hand lay-up or automated fiber placement (AFP) manufacturing applications. Park’s advanced composite materials are used to produce primary and secondary structures for jet engines, large and regional transport aircraft, military aircraft, Unmanned Aerial Vehicles (UAVs commonly referred to as “drones”), business jets, general aviation aircraft and rotary wing aircraft. Park also offers specialty ablative materials for rocket motors and nozzles and specially designed materials for radome applications. As a complement to Park’s advanced composite materials offering, Park designs and fabricates composite parts, structures and assemblies and low volume tooling for the aerospace industry. Target markets for Park’s composite parts and structures (which include Park’s proprietary composite SigmaStrut™ and AlphaStrut™ product lines) are, among others, prototype and development aircraft, special mission aircraft, spares for legacy military and civilian aircraft and exotic spacecraft. Park’s objective is to do what others are either unwilling or unable to do. When nobody else wants to do it because it is too difficult, too small or too annoying, sign us up.

Additional corporate information is available on the Company’s website at www.parkaerospace.com.

Contact:  Donna D’Amico-Annitto 486 North Oliver Road, Bldg. Z
Newton, Kansas 67114
(316) 283-6500
   



Posted on

Illinois Continues First-In-The-Nation Free Test Prep Program

Illinois Continues First-In-The-Nation Free Test Prep Program

Building on Governor Pritzker’s Affordability Agenda, the FY27 Proposed Budget will fund free test preparation courses through June 2027

CHICAGO–(BUSINESS WIRE)–
The Illinois Student Assistance Commission (ISAC) and global education company Kaplan today announced that Illinois’ first-in-the-nation free test preparation program – the Prepare for Illinois’ Future Program – will continue through the end of the academic school year. Additionally, Governor JB Pritzker has proposed to fund the program through the FY27 budget for another year as part of his Affordability Agenda and commitment to strengthening access to postsecondary opportunities.

Thirteen months after the launch of this program, in which the State has so far invested $9.9 million, more than 12,000 students registered for Kaplan’s free test prep courses, collectively saving students over $30 million. The Governor is recommending a $7 million appropriation for the program in FY27.

“As Governor, I am committed to making Illinois the best state in the nation to obtain an affordable education and pursue postsecondary opportunities,” said Governor JB Pritzker. “Thanks to our continued investments in career advancement tools like our first-in-the-nation free test prep program, we are making life more affordable for thousands of students by helping them prepare for their careers now and earn more in the future.”

The program has demonstrated strong outcomes for equity and workforce needs across the state:

  • Accelerating graduates’ transition into high-demand professions such as Engineering, Project Management, IT, and helping ensure a highly credentialed and licensed Illinois workforce.

  • More than 60% of participants identify as students of color, and low-income students are accessing preparation courses at five times their pre-program rate.

  • Nursing students who completed Kaplan NCLEX-RN preparation achieved a 97% predicted pass rate, far exceeding both Illinois and national averages, helping address the state’s critical nursing shortage.

  • Students completing MCAT preparation courses are on track to significantly increase medical school admissions rates for Black and Hispanic students, addressing long-standing gaps in Illinois’ physician pipeline.

The program offers Kaplan’s test and license preparation and workforce credentialing courses to all students enrolled in Illinois’ 12 public universities, and the program has been piloted at five community colleges chosen to reflect the geographic and demographic diversity of the state. Students at these institutions have received free access to Kaplan’s best-in-class preparation for professional licensing exams, graduate-level admissions exams, and credential exams, including comprehensive prep for the GRE®, GMAT®, LSAT®, MCAT®, NCLEX-RN®, USMLE®, Illinois State bar exam, real estate and securities exams, and more. The program is designed to increase earnings potential, expand the state’s tax base, and help employers fill critical workforce shortages.

“Even during a challenging budget year, Governor Pritzker’s recommendation to fund this program for FY27 reflects his ongoing commitment to improving educational access for Illinois students,” said ISAC Executive Director Eric Zarnikow. “Prepare for Illinois’ Future has not only offered a tremendous opportunity for our school partners and their students but has also proved to be a good investment for the state. The value of the courses offered thus far is about three times the initial appropriation, and the long-term benefit of investing in our students’ futures, improving access, and breaking down financial barriers, is incalculable.”

“The Prepare for Illinois’ Future program is a game-changing workforce development solution, unlocking opportunity and making higher education more affordable and accessible for hundreds of thousands of Illinois students. It’s already reshaping the landscape by opening new career pathways, ensuring that Illinois students aren’t just graduating, but are immediately qualified to enter high-demand careers and secure their futures,” said Gregory Marino, CEO, Kaplan North America. “The enthusiasm from students and communities all across the state we’ve seen over the past year since the program launched has been inspiring, and we look forward to continuing our work with the state’s colleges and universities and the Illinois Student Assistance Commission to help even more aspiring doctors, nurses, teachers, cybersecurity experts, engineers, and other essential professionals realize their full potential.”

Students enrolled in all Illinois public universities and at Joliet Junior College, Carl Sandburg College, Southwestern Illinois College, Malcolm X College, and Morton College can register for the Prepare for Illinois’ Future program to take advantage of free test preparation by visiting Go.Kaplan.com/Illinois.

Test names and other trademarks are the property of the respective trademark holders.

About ISAC

The mission of the Illinois Student Assistance Commission (ISAC) is to provide Illinois students with information and assistance to help make education beyond high school accessible and affordable. ISAC provides comprehensive, objective, and timely information about higher education and financial aid for students and their families—giving them access to the tools they need to make the educational choices that are right for them. Then, through the state scholarship and grant programs ISAC administers, ISAC can help students make those choices a reality. Find us at isac.org and follow us on Facebook, X, Instagram, and on YouTube.

About Kaplan

Kaplan, Inc. is a global education company that helps individuals and institutions advance their goals in an ever-changing world. Our broad portfolio of solutions helps students and professionals further their education and careers, universities and educational institutions attract and support students, and businesses maximize employee recruitment, retention, and development. Stanley Kaplan founded our company in 1938 with a mission to expand educational opportunities for students of all backgrounds. Today, our thousands of employees working in 27 countries/regions continue Stanley’s mission as they serve about 1.2 million students and professionals, 15,000 corporate clients, and 3,300 schools, school districts, colleges, and universities worldwide. Kaplan is a subsidiary of the Graham Holdings Company (NYSE: GHC). Learn more at Kaplan.com.

ISAC: Vera Mandilovitch

847.831.8620

[email protected]

Kaplan: Russell Schaffer

[email protected]

KEYWORDS: Illinois United States North America

INDUSTRY KEYWORDS: Public Policy/Government State/Local Teens Other Education University Primary/Secondary Consumer Education

MEDIA:

Logo
Logo